Understanding why older people participate in clinical trials: the experience of the Scottish PROSPER participants

Elizabeth P. Tolmie; Moira M.B. Mungall; Greig Louden; Grace M. Lindsay; Allan Gaw

doi:10.1093/ageing/afh109

Understanding why older people participate in clinical trials: the experience of the Scottish PROSPER participants

Elizabeth P. Tolmie, Moira M.B. Mungall, Greig Louden, Grace M. Lindsay, Allan Gaw

Nursing

Research output: Contribution to journal › Article › peer-review

Abstract

Over the next 20 years it is anticipated that there will be a significant increase in those aged 75 and over, and a consequent increase in cardiovascular disease, cancer and chronic illness. As this shift takes effect, there will be an increased need for treatment strategies that are of known benefit to this age group and a consequent rise in demand for clinical trials that are conducted specifically with the older population. Because factors that motivate older individuals to participate in clinical trials may differ from those that influence younger adults, it is important to evaluate the strategies used to encourage recruitment and retention and to determine how appropriate these are.

Original language	English
Journal	Age and Ageing
DOIs	https://doi.org/10.1093/ageing/afh109
Publication status	Published - 1 May 2004

Keywords

ageing
clinical trials

Documents and Links

10.1093/ageing/afh109

http://researchonline.gcu.ac.uk/health/33

Fingerprint Dive into the research topics of 'Understanding why older people participate in clinical trials: the experience of the Scottish PROSPER participants'. Together they form a unique fingerprint.

Cite this

@article{5bed1dd1cbd3451ca8fbe778a1e65f97,

title = "Understanding why older people participate in clinical trials: the experience of the Scottish PROSPER participants",

abstract = "Over the next 20 years it is anticipated that there will be a significant increase in those aged 75 and over, and a consequent increase in cardiovascular disease, cancer and chronic illness. As this shift takes effect, there will be an increased need for treatment strategies that are of known benefit to this age group and a consequent rise in demand for clinical trials that are conducted specifically with the older population. Because factors that motivate older individuals to participate in clinical trials may differ from those that influence younger adults, it is important to evaluate the strategies used to encourage recruitment and retention and to determine how appropriate these are.",

keywords = "ageing, clinical trials",

author = "Tolmie, {Elizabeth P.} and Mungall, {Moira M.B.} and Greig Louden and Lindsay, {Grace M.} and Allan Gaw",

note = "Originally published in: Age and Ageing (2004), 33 (4), pp.374-378.",

year = "2004",

month = may,

day = "1",

doi = "10.1093/ageing/afh109",

language = "English",

journal = "Age and Ageing",

issn = "0002-0729",

publisher = "Oxford University Press",

}

TY - JOUR

T1 - Understanding why older people participate in clinical trials: the experience of the Scottish PROSPER participants

AU - Tolmie, Elizabeth P.

AU - Mungall, Moira M.B.

AU - Louden, Greig

AU - Lindsay, Grace M.

AU - Gaw, Allan

N1 - Originally published in: Age and Ageing (2004), 33 (4), pp.374-378.

PY - 2004/5/1

Y1 - 2004/5/1

N2 - Over the next 20 years it is anticipated that there will be a significant increase in those aged 75 and over, and a consequent increase in cardiovascular disease, cancer and chronic illness. As this shift takes effect, there will be an increased need for treatment strategies that are of known benefit to this age group and a consequent rise in demand for clinical trials that are conducted specifically with the older population. Because factors that motivate older individuals to participate in clinical trials may differ from those that influence younger adults, it is important to evaluate the strategies used to encourage recruitment and retention and to determine how appropriate these are.

AB - Over the next 20 years it is anticipated that there will be a significant increase in those aged 75 and over, and a consequent increase in cardiovascular disease, cancer and chronic illness. As this shift takes effect, there will be an increased need for treatment strategies that are of known benefit to this age group and a consequent rise in demand for clinical trials that are conducted specifically with the older population. Because factors that motivate older individuals to participate in clinical trials may differ from those that influence younger adults, it is important to evaluate the strategies used to encourage recruitment and retention and to determine how appropriate these are.

KW - ageing

KW - clinical trials

U2 - 10.1093/ageing/afh109

DO - 10.1093/ageing/afh109

M3 - Article

JO - Age and Ageing

JF - Age and Ageing

SN - 0002-0729

ER -